Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatment by D. T. Wademan, H. R. Draper, S. E. Purchase, M. Palmer, A. C. Hesseling, L. Van der Laan, A. J. Garcia-Prats

Get full text

Acceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatment by S.E. Purchase, J. Brigden, J.A. Seddon, N.A. Martinson, L. Fairlie, S. Staples, A. Poswa, T. Duong, H.S. Schaaf, A.C. Hesseling

Get full text

Children’s preferences among six novel moxifloxacin and linezolid-dispersible tablet formulations by G. Hoddinott, H.R. Draper, N. Vanqa, S. Myeni, S. Staples, T. Sachs, M. Raffique, N. Tshethu, M. Palmer, L. Viljoen, K. Inabathina, R. Taneja, A.C. Hesseling, A.J. Garcia-Prats

Get full text

Lung function trajectories in children with pulmonary TB and non-TB lower respiratory tract infections by I.J. Courtney, M. Palmer, R. Swanepoel, C.J. Lombard, M. van Niekerk, R. Dunbar, E.D. McCollum, H.S. Schaaf, A. Gie, P. Goussard, A.C. Hesseling, V.W. Jongen, M.M. van der Zalm

Get full text

Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countries by L. Viljoen, H.R. Draper, N.T. Castillo-Carandang, N. Suryavanshi, A. Marthinus, A.M.A. Cheong, J.D.D. Ocampo, G. Dhumal, S. Bagchi, D.T. Wademan, A. Kinikar, M. Paradkar, M.V.G. Frias IV, D.J.O. Casalme, A.C. Hesseling, A.J. Garcia-Prats, M. Palmer, G. Hoddinott, on behalf of the CATALYST trial team

Get full text